Artificial Intelligence- Is It the “Next Big Thing” in Healthcare?

Published May 23, 2018

Panel Discusses the Potential and the Challenges for AI in Healthcare Decision Making

Baltimore, MD, USA—May 23, 2018—ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, “Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?” [IP21], at ISPOR 2018 in Baltimore, MD, USA. Artificial Intelligence (AI) can be used to analyze medical data for diagnostic, therapeutic, and predictive models. The use of AI, however, is still controversial with concerns over privacy and validity of results being debated. This panel was moderated by Santiago Ernesto Herran, MD, Bayer Andina, Bogotá, Colombia. Panelists included: Rafael Alfonso Cristancho, MD, MSc, PhD, GlaxoSmithKline, Collegeville, PA, USA; Juan-David Rueda, MD, MS, University of Maryland School of Pharmacy, Baltimore, MD, USA; and Carrie Savage Bennette, PhD, MPH, Flatiron, New York, NY, USA. Dr Rueda presented examples of successful use of AI in healthcare and explored its potential benefits, including optimization of available data, early adoption, and potential decrease of human error when analyzing large amounts of complex data. Dr Alfonso focused on the limitations of data privacy, challenges of AI algorithm validations, and the potential lack of accountability from developers compared to those using AI for healthcare decision making. Dr Bennette focused on the operational and analytic challenges in applying AI methods to real-world data and discussed the distinction between AI as a tool and AI as a product. Additional information on ISPOR 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBaltimore.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×